Novartis takes the hot seat in China corruption probe

Big Pharma, beware of your former (and possibly current) employees in China. Novartis ($NVS) is the latest drugmaker to be fingered for bribery by an anonymous whistleblower, just a few days after Sanofi ($SNY) got the same treatment. And Chinese officials say they're stepping up their pharma investigation even further. Report

Add new comment

Images
More information
  • Files must be less than 2 MB.
  • Allowed file types: png gif jpg jpeg.
Documents
More information
  • Files must be less than 2 MB.
  • Allowed file types: zip rar.